Johnson & Johnson
31
26M
30
0.23
10
0.03
4
- Areas of investment
Summary
In 1886 was created Johnson & Johnson, which is appeared as Corporate Investor. The venture was found in North America in United States. The leading representative office of defined Corporate Investor is situated in the New Brunswick.
The fund is generally included in less than 2 deals every year. Considering the real fund results, this Corporate Investor is 18 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2016. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2014. The common things for fund are deals in the range of 50 - 100 millions dollars. Comparing to the other companies, this Johnson & Johnson performs on 4 percentage points less the average number of lead investments.
We also calculated 24 valuable employees in our database.
Among the most popular fund investment industries, there are Internet of Things, Health Diagnostics. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight TESARO, Crucell, DayTwo. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 3 or 4 of the founder, the chance for it to get the investment is meager. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
The usual cause for the fund is to invest in rounds with 4 partakers. Despite the Johnson & Johnson, startups are often financed by Xavier Niel, Social Capital, SOSV. The meaningful sponsors for the fund in investment in the same round are Seventure Partners, Medtronic, aMoon Fund. In the next rounds fund is usually obtained by Samsung NEXT, Omri Casspi, Longliv Ventures.
Investments analytics
Analytics
- Total investments
- 31
- Lead investments
- 10
- Exits
- 4
- Rounds per year
- 0.23
- Follow on index
- 0.03
- Investments by industry
- Health Care (23)
- Wellness (5)
- Medical Device (5)
- Information Technology (4)
- Biotechnology (4) Show 43 more
- Investments by region
-
- United States (18)
- Israel (1)
- Singapore (1)
- China (1)
- Uganda (2) Show 6 more
- Peak activity year
- 2021
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 87M
- Group Appearance index
- 0.65
- Avg. company exit year
- 10
- Avg. multiplicator
- 1.94
- Strategy success index
- 0.60
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| mClinica | 09 Feb 2023 | Health Care, Big Data, Pharmaceutical, mHealth | Early Stage Venture | 10M | Central, Singapore, Singapore |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.